logo
Body Fat More Accurately Predicts Heart Disease, Death Risk Than BMI

Body Fat More Accurately Predicts Heart Disease, Death Risk Than BMI

Health Line21 hours ago
A new study reports that measurements that detect body fat are a more accurate predictor of mortality risk than body mass index (BMI).
Experts say BMI doesn't differentiate between weight attributed to body fat and weight attributed to muscle.
They do note that BMI is easier to calculate and less expensive than many body fat measurements.
Body mass index (BMI) only tells part of the story when it comes to determining your overall health and death risk.
Measurements that calculate body fat percentage are significantly more accurate for determining health profiles, according to a new study published Annals of Family Medicine.
Compared to BMI scores, researchers said body-fat percentages were a stronger predictor of the 15-year mortality risk of young adults ages 20 to 49.
They reported that people with high body fat are 78% more likely to die from any cause compared to people without high body fat.
In addition, those with elevated body fat percentages have a 262% higher chance of dying from heart disease.
The researchers said BMI measurements did not detect these risks, but other measurements did. These included bioelectrical impedance analysis (BIA), which uses electrical current to measure body fat, muscle mass, and water weight.
'Body fat percentage is a better predictor of 15-year mortality risk factor in young adults than BMI. A move to using [body fat percentages] rather than BMI may change how we measure body composition for risk stratification,' the researchers wrote.
For their study, the researchers analyzed data on 4,252 males and females who participated in the 1994 to 2004 National Health and Nutrition Examination Survey (NHANES). They then compared those records with data from the National Death Index through 2019.
Experts not involved in the study say the results are not surprising.
'Previous studies have shown similar results — measuring body fat, especially fat deep in the belly which is close to organs, more metabolically active and plays a greater metabolic risk, may be a better assessment than simply a number on the scale which cannot assess variations between muscle, fat, water, etc.,' said Kristin Kirkpatrick, RD, the president of KAK Consulting and a dietitian at the Cleveland Clinic Dept of Department of Wellness & Preventive Medicine.
BMI is more accessible but not as accurate
The concept of body mass index (BMI) was developed in 1832 by Belgian mathematician Lambert Adolphe Jacques Quetelet.
It's calculated by basically dividing a person's weight by their height squared. There are free calculators online to help do the math.
Using that scale, medical professionals classify body composition of adults in the following way.
less than 18.5 — underweight
18.5 to 24.9 — healthy weight
25 to 29.9 — overweight
30 or greater — obesity
Obesity is classified by three subtypes using BMI:
class 1 obesity — 30 to 34.9
class 2 obesity — 35 to 39.9
class 3 obesity — 40 or higher
Ali said the advantages of measuring BMI are that it's a well-known gauge that is easy to calculate, relatively inexpensive, and generally accepted by insurance.
Some past studies have shown that BMI can be a predictor of chronic diseases such as:
type 2 diabetes
cancer
kidney disease
Mir Ali, MD, a general surgeon, bariatric surgeon, and the medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in California, said BMI doesn't distinguish between weight obtained by muscle and weight due to body fat.
'It doesn't take into account the differences between fat and muscle in the body,' Ali told Healthline. 'BMI is not necessarily the best measurement for body composition — it's more of a guidance.'
Becca Krukowski, PhD, a professor of public health services at the University of Virginia and a fellow at the Obesity Society, said BMI measurements have several shortcomings.
'BMI is widely used in clinical settings because it is easy to compute,' she told Healthline.
'However, BMI is a rough measure of body composition, and individuals can be misclassified with overweight or obesity if they are extremely muscular. In addition, someone with a BMI in the 'normal' category could still have a high body fat percentage, which still increases their risk of many chronic diseases,' Krukowski continued.
Kirkpatrick expressed similar concerns.
'BMI may offer a general assessment — and the location of fat in the body matters related to risk, [but] the major disadvantage [of BMI] is not being able to assess health risk simply based on the number,' she told Healthline.
Measuring body fat percentage
In their study, researchers said bioelectrical impedance analysis bioelectrical impedance analysis (BIA) is a more accurate way of predicting future health issues.
This system works by sending small electric currents throughout the body. Electrodes on the skin measures these currents after they pass through body tissues. These currents move easier through muscle than fat.
Other methods of measuring body fat include dual-energy X-ray absorptiometry (DEXA) and body circumference measurements.
Kirkpatrick said these types of body fat measurements provide a better overall picture.
'[Body fat] assessment (and looking at where fat is stored) can help assess risk,' she explained.
'For example, fat stored in the belly is much more dangerous in terms of metabolic risk than fat that is stored in the thighs and buttocks. Genetics play a role as well, with some individuals having more risk based on other factors.'
Ali agreed. 'Body fat may be a better measurement of overall health,' he said, noting the disadvantages of these types of measurements are that they can be more expensive and they aren't as easy to calculate as BMI.
Krukowski noted similar limitations. 'Each of these methods have their pros and cons,' she said.
'Dual-energy X-ray absorptiometry (DEXA) scans are very accurate, but quite expensive and not available in many clinical settings. Although waist circumference measurement can be quite helpful in predicting disease risk, it is very complicated to do correctly. Finally, as the authors note in the article, bioelectrical impedance analysis machines have not always been able to provide accurate measurement of body fat percentage,' Krukowski continued.
'However, this article indicates that perhaps this bioelectrical impedance analysis technology has improved enough to seriously consider this technology in estimating body fat percentage,' she added.
Ali noted there are simple ways for people to assess their overall health, too. For example, if you have trouble walking up stairs or standing up after kneeling, your overall health may not be where it should be.
Obesity and health risks
The Centers for Disease Control and Prevention (CDC) estimates that 40% of U.S. adults have obesity.
The condition has a higher prevalence in people in certain groups, including non-Hispanic Black adults and people with less education.
There are many health risks associated with obesity. Among them:
heart disease
stroke
high blood pressure
liver disease
certain cancers
pregnancy complications
Experts say you can lower your risk of obesity by following a healthy lifestyle of exercise and diet.
For exercise, it's recommended to aim for at least 150 minutes a week of moderate aerobic activity.
For diet, experts advise:
filling half your plate with vegetables
eating more whole grains
choosing lean sources of protein (i.e., chicken and seafood)
avoiding fried foods
avoiding sugary foods
avoiding or abstaining from alcohol
'Body weight is just one component of fitness and health,' said Kirkpatrick. 'Dietary patterns, sleep, exercise habits, genetics, and environment all may play a role in an individual's health status.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

HRT ‘can raise breast cancer risk' in younger women
HRT ‘can raise breast cancer risk' in younger women

Yahoo

time17 minutes ago

  • Yahoo

HRT ‘can raise breast cancer risk' in younger women

Hormone replacement therapy can raise the risk of breast cancer in some younger women, a Lancet study suggests. An international team of researchers found the treatment was not linked to young onset breast cancer overall. But oestrogen plus progestin therapy appears to increase breast cancer risk by 10 per cent. Meanwhile, oestrogen hormone therapy use appeared to decrease breast cancer risk by 14 per cent. Hormone replacement therapy is a treatment used to help menopause symptoms. There are different types of HRT, which is used to treat menopause symptoms, available. They contain different hormones: some are oestrogen products; others contain progestogen and other types have both. These medicines can be taken or used in different ways and work by replacing the hormones oestrogen and progesterone, which can fall to lower levels as women approach the menopause. Most studies examining links between hormone therapy and breast cancer risk have been explored in older women. Previous work, which has focused on women who have already been through the menopause, suggest that oestrogen plus progestin hormone therapy is a risk factor for breast cancer. The researchers, led by academics from the National Institute of Environmental Health Sciences in the US, wanted to explore the risks among younger women on hormone therapy – who may take these drugs after gynaecological surgery or during perimenopause. The new meta-analysis published in the journal, Lancet Oncology, examined data drawn from previous studies of 459,476 women aged 16 to 54 years old. Some two per cent of this group (8,455) developed young-onset breast cancer, which means the disease was diagnosed before they were 55 years old. And 15 per cent of women involved in the study reported using hormone therapy, with oestrogen plus progestin hormone therapy and oestrogen being the most common types. 'Although the strength of these associations might vary by age at first use, duration of use, gynaecological surgery status, and other factors, unopposed oestrogen hormone therapy use appears to decrease breast cancer risk and oestrogen plus progestin therapy appears to increase breast cancer risk,' the authors wrote. 'The findings can be used to augment clinical recommendations for hormone therapy use in young women, for whom guidance was previously scarce.' Dr Kotryna Temcinaite, the head of research communications at Breast Cancer Now, said: 'These results are largely in line with what we already know about taking HRT for menopausal symptoms and its effects on breast cancer risk – for most people, the risk of developing breast cancer because of taking HRT is small and is outweighed by the benefits. 'Taking HRT is a very personal decision and, as such, it's vital that everyone has the information they need on the benefits and risks, discusses them with their GP or specialist team and is supported to make the choice that's right for them.' Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy
Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy

Yahoo

time18 minutes ago

  • Yahoo

Elevance Health Insiders Sold US$6.9m Of Shares Suggesting Hesitancy

Over the past year, many Elevance Health, Inc. (NYSE:ELV) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, if numerous insiders are selling, shareholders should investigate more. While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. In the last twelve months, the biggest single sale by an insider was when the Executive VP & President of Commercial Health Benefits, Charles Kendrick, sold US$3.2m worth of shares at a price of US$432 per share. That means that an insider was selling shares at around the current price of US$396. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern. Elevance Health insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below! View our latest analysis for Elevance Health If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar). Over the last three months, we've seen significant insider selling at Elevance Health. Specifically, Executive VP & CFO Mark Kaye ditched US$1.9m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain. For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Elevance Health insiders own 0.1% of the company, currently worth about US$103m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders. An insider hasn't bought Elevance Health stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Elevance Health. But note: Elevance Health may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Trump Made Bizarre Request At Hospital After Assassination Attempt: Book
Trump Made Bizarre Request At Hospital After Assassination Attempt: Book

Yahoo

time23 minutes ago

  • Yahoo

Trump Made Bizarre Request At Hospital After Assassination Attempt: Book

Donald Trump asked the doctor treating him for his gunshot wound last July if he could have a CT scan image because it's 'like an IQ test,' according to a new book. The Washington Post published an excerpt from '2024: How Trump Retook the White House and the Democrats Lost America' detailing the day of the assassination attempt on him in Butler, Pennsylvania. A portion of it contained the curious item of Trump making his scan request to the physician and walking down the hall with a phalanx of Secret Service agents to get the scan. Here's the rest of the passage: He asked to see the 'film' from the scan. The doctor said that wasn't done anymore, and offered him a written report. 'I want the film,' he repeated. [Co-campaign manager Susie Wiles] left to get a copy of the image, and while she was gone, one of the aides asked him why. 'It's like an IQ test,' Trump said. 'They tell you that your brain is good, so I just want to have that.' Wiles put the images in a manila envelope in her bag. Brain CT scans are used to detect tumors, bleeding, or other abnormalities, but they do not measure intelligence, according to Johns Hopkins Medicine. However, another type of scan, the MRI, is thought to indicate intellectual capacity as brain activity is tracked at rest, Caltech reported. A study showed that infants' IQ could potentially be predicted using the MRI. Trump has been known to obsess over IQ, and the timing of his request might have had to do with his race against then Democratic nominee Joe Biden. While Biden bore the brunt of concerns over cognitive ability at the time, Trump also faced questions. Biden withdrew from the race about a week later and was replaced by Vice President Kamala Harris. Trump, of course, won the election but has not quelled accusations of impairment. HuffPost has reached out to Trump's team for comment. Lawrence O'Donnell's Unfiltered Reaction To Bonkers Trump Presser Moment Says It All Trump's Tax Bill Plans To Decimate Medicaid. For One Group, The Cuts Will Be Unspeakably Cruel. From Name-Calling To Love-Bombing: Trump Mocked For DeSantis Flip-Flop

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store